ResearchMoz

China Japanese Encephalitis Vaccine Industry 2013 Deep Research Report

QYResearch
Published Date » 2013-03-04
No. Of Pages » 63
   
 This report has firstly introduced Japanese Encephalitis Vaccine definition classification industry chain etc related information. Then introduced Japanese Encephalitis Vaccine manufacturing technology and product specifications, And then summary statistics China major Japanese Encephalitis Vaccine manufacturers 2010-2016 Japanese Encephalitis Vaccine capacity production supply demand shortage and Japanese Encephalitis Vaccine selling price cost gross margin and production value, and also introduced China 5 manufacturers company basic information, 2010-2016 Japanese Encephalitis Vaccine capacity production price cost gross margin production value China market share etc details information.  
   
 In the end, this report introduced 4Million Doses/year Japanese Encephalitis...
Table of Contents

Chapter One Japanese Encephalitis Vaccine (BHK) Industry Overview 1
1.1 Japanese Encephalitis Vaccine (BHK) Definition 1
1.2 Japanese Encephalitis Vaccine (BHK) Product Specification 2
1.3 Japanese Encephalitis Vaccine (BHK) Price Analysis 3
1.4 Japanese Encephalitis Vaccine (BHK) Manufacturing Process 4
1.5 Japanese Encephalitis Vaccine (BHK) Cost Structure 5
1.6 Japanese Encephalitis Vaccine (BHK) Industry Overview 6

Chapter Japanese Encephalitis Vaccine (Vero Cell) Industry Overview 6
2.1 Japanese Encephalitis Vaccine (Vero Cell) Definition 6
2.2 Japanese Encephalitis Vaccine (Vero Cell) Product Specification 8
2.3 Japanese Encephalitis Vaccine (Vero Cell) Price Analysis 9
2.4 Japanese Encephalitis Vaccine (Vero Cell) Manufacturing Process 10
2.5 Japanese Encephalitis Vaccine (Vero Cell) Cost Structure 11
2.6 Japanese Encephalitis Vaccine (Vero Cell) Industry Overview 12

Chapter Three Japanese Encephalitis Vaccine Industry Chain Analysis 12
3.1 Raw Materials Market Analysis 12
3.2 Vaccination Requirement Analysis 13
3.3 Raw Materials-Japanese Encephalitis Vaccine - Vaccinated People Industry Chain Analysis 15

Chapter Four Japanese Encephalitis Vaccine Production Supply Sales Demand Market Status and Forecast 16
4.1 China Japanese Encephalitis Vaccine Capacity Production Overview 16
4.2 China Regional Japanese Encephalitis Vaccine Production and Market Share 23
4.3 China Japanese Encephalitis Vaccine Sales and Market Share 24
4.4 China Key Manufacturers Japanese Encephalitis Vaccine Capacity Utilization Rate 26
4.5 China Japanese Encephalitis Vaccine (BHK Vero Cell) Capacity Production and Market Share 27
4.6 China Japanese Encephalitis Vaccine Demand Overview 29
4.7 China Japanese Encephalitis Vaccine Supply Demand Shortage 29
4.8 China Japanese Encephalitis Vaccine Cost Price Production Value Gross Margin 30
4.9 China Japanese Encephalitis Vaccine Import Export Consumption 31

Chapter Five Japanese Encephalitis Vaccine Key Manufacturers Research 32
5.1 Chengdu Institute of Biological Products Co.,Ltd 32
5.2 Wuhan Institute of Biological Products Co.,Ltd 36
5.3 Lanzhou Institute of Biological Products Co.,Ltd 39
5.4 Beijing Tiantan Biological Products Co.,Ltd 43
5.5 Liaoning Chengda Biotechnology 48
5.6 Other Manufacturers 53

Chapter Six Japanese Encephalitis Vaccine New Project Investment Feasibility Analysis 53
6.1 Japanese Encephalitis Vaccine Project SWOT Analysis 53
6.2 Japanese Encephalitis Vaccine New Project Investment Feasibility Analysis 54

Chapter Seven Japanese Encephalitis Vaccine Industry Research Conclusions 55

List of Tables


Figure Japanese Encephalitis Vaccine (BHK) Product Picture 1
Table Japanese Encephalitis Vaccine (BHK) Product Specifications List 2
Table 2010-2016 China Japanese Encephalitis Vaccine (BHK) Price (RMB/Dose) List 3
Figure Japanese Encephalitis Vaccine Manufacturing Process Flow 4
Table Japanese Encephalitis Vaccine (BHK) Product Equipments List 5
Table 2010-2016 China Japanese Encephalitis Vaccine Price Cost Gross (RMB/Dose) Gross Margin List 5
Table 2012 China Japanese Encephalitis Vaccine Cost Structure (RMB/Dose) 6
Figure Japanese Encephalitis Vaccine (Vero Cell) Product Picture 7
Table Japanese Encephalitis Vaccine (Vero) Product Specifications List 8
Table 2010-2016 China Japanese Encephalitis Vaccine Price (RMB/Dose) List 9
Figure Japanese Encephalitis Vaccine (Vero Cell) Manufacturing Process Flow 10
Table Japanese Encephalitis Vaccine (Vero Cell) Product Equipments List 10
Table 2010-2016 China Japanese Encephalitis Vaccine (Vero Cell) Price Cost Gross (RMB/Dose) Gross Margin List 11
Table 2012 China Japanese Encephalitis Vaccine (Vero Cell) Cost Structure (RMB/Dose) 11
Table 2010-2016 China Japanese Encephalitis Vaccine 199 Medium Price (RMB/Bottle) List 13
Table 2010-2016 China BSA Price (RMB/Bottle) List 13
Table 2007-2013 China Number of Patients Died of Rabies (People) 13
Table 2010-2016 China Japanese Encephalitis Vaccine Demand (10K Doses) List 14
Figure 2010-2016 China Japanese Encephalitis Vaccine Demand (10K Doses) and Growth Rate 14
Figure Raw Materials-Japanese Encephalitis Vaccine - Vaccinated People Industry Chain Structure 15
Table Raw Materials-Japanese Encephalitis Vaccine - Vaccinated People Industry Chain Related Suppliers Product Shipment and Supply Relationship List 15
Table 2010-2016 China Key Manufacturers Japanese Encephalitis Vaccine Capacity and Total Capacity (10K Doses) List 16
Table 2010-2016 China Key Manufacturers Japanese Encephalitis Vaccine Capacity Market Share List 16
Table 2010-2016 China Key Manufacturers Japanese Encephalitis Vaccine Production and Total Production (10K Doses) List 17
Table 2010-2016 China Key Manufacturers Japanese Encephalitis Vaccine Production Market Share List 17
Figure 2010-2016 China Japanese Encephalitis Vaccine Capacity Production (10K Doses) and Growth Rate 18
Table 2010-2016 China Japanese Encephalitis Vaccine Capacity Utilization Rate List 18
Table 2010-2016 China Key Manufacturers Japanese Encephalitis Vaccine (BHK) Capacity and Total Capacity (10K Doses) List 19
Table 2010-2016 China Key Manufacturers Japanese Encephalitis Vaccine (BHK) Capacity Market Share List 19
Table 2010-2016 China Key Manufacturers Japanese Encephalitis Vaccine (BHK) Production and Total Production (10K Doses) List 19
Table 2010-2016 China Key Manufacturers Japanese Encephalitis Vaccine (BHK) Production Market Share List 19
Figure 2010-2016 China Japanese Encephalitis Vaccine (BHK) Capacity Production (10K Doses) and Growth Rate 20
Table 2010-2016 China Japanese Encephalitis Vaccine (BHK) Capacity Utilization Rate List 20
Table 2010-2016 China Key Manufacturers Japanese Encephalitis Vaccine (Vero Cell) Capacity and Total Capacity (10K Doses) List 21
Table 2010-2016 China Key Manufacturers Japanese Encephalitis Vaccine (Vero Cell) Capacity Market Share List 21
Table 2010-2016 China Key Manufacturers Japanese Encephalitis Vaccine (Vero Cell) Production and Total Production (10K Doses) List 21
Table 2010-2016 China Key Manufacturers Japanese Encephalitis Vaccine (Vero Cell) Production Market Share List 21
Figure 2010-2016 China Japanese Encephalitis Vaccine (Vero Cell) Capacity Production (10K Doses) and Growth Rate 22
Table 2010-2016 China Japanese Encephalitis Vaccine (Vero Cell) Capacity Utilization Rate List 22
Table 2010-2016 Sichuan Hunan Gansu Beijing Liaoning etc Regions Japanese Encephalitis Vaccine Capacity (10K Doses) List 23
Table 2010-2016 Sichuan Hunan Gansu Beijing Liaoning etc Regions Japanese Encephalitis Vaccine Capacity Market Share List 23
Table 2010-2016 Sichuan Hunan Gansu Beijing Liaoning etc Regions Japanese Encephalitis Vaccine Production (10K Doses) List 23
Table 2010-2016 Sichuan Hunan Gansu Beijing Liaoning etc Regions Japanese Encephalitis Vaccine Production Market Share List 24
Table 2010-2016 China Japanese Encephalitis Vaccine Sales (10K Doses) List 24
Table 2010-2016 China Japanese Encephalitis Vaccine Sales Market Share List 24
Table 2010-2016 China Japanese Encephalitis Vaccine (BHK) Sales (10K Doses) List 25
Table 2010-2016 China Japanese Encephalitis Vaccine (BHK) Sales Market Share List 25
Table 2010-2016 China Japanese Encephalitis Vaccine (Vero Cell) Sales (10K Doses) List 25
Table 2010-2016 China Japanese Encephalitis Vaccine (Vero Cell) Sales Market Share List 26
Table 2010-2016 China Key Manufacturers Japanese Encephalitis Vaccine Capacity Utilization Rate List 26
Table 2010-2016 China Key Manufacturers Japanese Encephalitis Vaccine (BHK) Capacity Utilization Rate List 26
Table 2010-2016 China Key Manufacturers Japanese Encephalitis Vaccine (Vero Cell) Capacity Utilization Rate List 27
Table 2010-2016 China Japanese Encephalitis Vaccine (BHK Vero Cell) Capacity (10K Doses) List 27
Table 2010-2016 China Japanese Encephalitis Vaccine (BHK Vero Cell) Capacity Market Share List 27
Table 2010-2016 China Japanese Encephalitis Vaccine (BHK Vero Cell) Production (10K Doses) List 27
Table 2010-2016 China Japanese Encephalitis Vaccine (BHK Vero Cell) Production Market Share List 28
Table 2010-2016 China Japanese Encephalitis Vaccine (BHK Vero Cell) Sales (10K Doses) List 28
Table 2010-2016 China Japanese Encephalitis Vaccine (BHK Vero Cell) Sales Market Share List 28
Table 2010-2016 China Japanese Encephalitis Vaccine Demand (10K Doses) List 29
Table 2010-2016 China Japanese Encephalitis Vaccine Supply Demand Shortage (10K Doses) List 29
Table 2010-2016 China Japanese Encephalitis Vaccine Production (10K Doses) Price Cost Gross (RMB/Dose) Production Value (10K RMB) Gross Margin List 30
Table 2010-2016 China Japanese Encephalitis Vaccine (BHK) Production (10K Doses) Price Cost Gross (RMB/Dose) Production Value (10K RMB) Gross Margin List 30
Table 2010-2016 China Japanese Encephalitis Vaccine (Vero Cell) Production (10K Doses) Price Cost Gross (RMB/Dose) Production Value (10K RMB) Gross Margin List 31
Table 2010-2016 China Japanese Encephalitis Vaccine Import Export Consumption (10K Doses) List 31
Table Chengdu Institute of Biological Products Co.,Ltd  Company Information Table (Product Application Market Position Capacity Expansion Plan Contact Information etc 12 Items) 32
Figure Chengdu Institute of Biological Products Co.,Ltd  Japanese Encephalitis Vaccine (BHK) Product Picture 33
Table Chengdu Institute of Biological Products Co.,Ltd  Japanese Encephalitis Vaccine (BHK) Product Specifications List 34
Table 2010-2016 Chengdu Institute of Biological Products Co.,Ltd  Japanese Encephalitis Vaccine Capacity Production (10K Doses) Price Cost Gross (RMB/Dose) Production Value (10K RMB) Gross Margin List 35
Figure 2010-2016 Chengdu Institute of Biological Products Co.,Ltd  Japanese Encephalitis Vaccine Capacity Production (10K Doses) and Growth Rate 35
Table Wuhan Institute of Biological Products Co.,Ltd Company Information Table (Product Application Market Position Capacity Expansion Plan Contact Information etc 12 Items) 36
Figure Wuhan Institute of Biological Products Co.,Ltd Japanese Encephalitis Vaccine (BHK) Product Picture 37
Table Wuhan Institute of Biological Products Co.,Ltd Japanese Encephalitis Vaccine (BHK) Product Specifications List 37
Table 2010-2016 Wuhan Institute of Biological Products Co.,Ltd Japanese Encephalitis Vaccine Capacity Production (10K Doses) Price Cost Gross (RMB/Dose) Production Value (10K RMB) Gross Margin List 38
Figure 2010-2016 Wuhan Institute of Biological Products Co.,Ltd Japanese Encephalitis Vaccine Capacity Production (10K Doses) and Growth Rate 39
Table Lanzhou Institute of Biological Products Co.,Ltd  Company Information Table (Product Application Market Position Capacity Expansion Plan Contact Information etc 12 Items) 39
Figure Lanzhou Institute of Biological Products Co.,Ltd Japanese Encephalitis Vaccine (BHK) Product Picture 41
Table Lanzhou Institute of Biological Products Co.,Ltd Japanese Encephalitis Vaccine (BHK) Product Specifications List 42
Table 2010-2016 Lanzhou Institute of Biological Products Co.,Ltd Japanese Encephalitis Vaccine Capacity Production (10K Doses) Price Cost Gross (RMB/Dose) Production Value (10K RMB) Gross Margin List 42
Figure 2010-2016 Lanzhou Institute of Biological Products Co.,Ltd Japanese Encephalitis Vaccine Capacity Production (10K Doses) and Growth Rate 43
Table Beijing Tiantan Biological Products Co.,Ltd Company Information Table (Product Application Market Position Capacity Expansion Plan Contact Information etc 12 Items) 44
Figure Beijing Tiantan Biological Products Co.,Ltd Japanese Encephalitis Vaccine (Vero Cell) Product Picture 45
Table Beijing Tiantan Biological Products Co.,Ltd Japanese Encephalitis Vaccine (Vero Cell) Product Specifications List 46
Table 2010-2016 Beijing Tiantan Biological Products Co.,Ltd Japanese Encephalitis Vaccine Capacity Production (10K Doses) Price Cost Gross (RMB/Dose) Production Value (10K RMB) Gross Margin List 47
Figure 2010-2016 Beijing Tiantan Biological Products Co.,Ltd Japanese Encephalitis Vaccine Capacity Production (10K Doses) and Growth Rate 48
Table Liaoning Chengda Biotechnology Company Information Table (Product Application Market Position Capacity Expansion Plan Contact Information etc 12 Items) 48
Figure Liaoning Chengda Biotechnology Japanese Encephalitis Vaccine (Vero Cell) Product Picture 50
Table Liaoning Chengda Biotechnology Japanese Encephalitis Vaccine (Vero Cell) Product Specifications List 50
Table 2010-2016 Liaoning Chengda Biotechnology Japanese Encephalitis Vaccine Capacity Production (10K Doses) Price Cost Gross (RMB/Dose) Production Value (10K RMB) Gross Margin List 52
Figure 2010-2016 Liaoning Chengda Biotechnology Japanese Encephalitis Vaccine Capacity Production (10K Doses) and Growth Rate 53
Table 2013 China Japanese Encephalitis Vaccine New Project SWOT Analysis List 53
Table 4 million Doses/Year Lyophilized Human Japanese Encephalitis Vaccine (Vero Cell) New Project Investment Return Rate and Project Feasibility Analysis List 54

List of Figures

Upcoming Reports:

Poland: market of synthetic staple fibres yarn
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the synthetic staple fibers yarn market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the synthetic staple fibers yarn market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report...
Poland: industrial brewery machinery market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the industrial brewery machinery market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the industrial brewery machinery market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report...
Poland: cauliflowers and broccoli market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the cauliflowers and broccoli market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the cauliflowers and broccoli market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

New Drug Shows Early Promise against Heart Attacks and Strokes
Sep 1, 2014  
Sanofi and Regeneron Pharmaceuticals have been working on a new experimental drug that aims to lower cholesterol. Early tests have shown that the drug cuts down risks of heart attacks and strokes in clinical trials by half. The test report says that the results are not conclusive as the analysis was performed retrospectively. The study does provide the positive result that...
New Materials Creation Strategy
Sep 1, 2014  
Scientists always aim at theorizing about new compounds and materials; however after Researchers have made use of X-ray scattering in a process known as molecular beam epitaxy (MBE) to understand atom behavior as a kind of material called as layered oxides were getting formed. For computational predictions of new materials, the available observations were utilized for providing insights on...
Western Africa economies hit by Ebola travel ban
Aug 28, 2014  
With over 1,400 people dead due to the fatal Ebola outbreak in African countries, travel services have either banned or limited operations to the western region, severely hitting economies of the area. Budgetary resources are being utilized rapidly and economic growth has dropped by 4% as international projects and trips have been cancelled. Transport companies have cut off the region...
Fonterra Ties Up With Beingmate to Tap into China’s Baby Food Market
Aug 28, 2014  
Fonterra Co-Operative Group Ltd. will partner with Beingmate Group Co, China’s biggest infant formula manufacturer to increase its reach in the Chinese market. The New Zealand-based company makes this move with the intent to grab a bigger market share in China after it suffered many setbacks in the food-safety scandal last year.   This partnership will also help Beingmate...
Chinas Leading Asset-Management Company Aims for IPO
Aug 28, 2014  
China’s biggest asset-management company plans to go public by the end of 2015. Chinese authorities are constantly ramping up their interests towards introducing mixed ownership to state-owned huge companies and call for more private capital investments into the economy. According to the news report, China Huarong Asset Management Co., Ltd. will collaborate with eight investors...